Viking Therapeutics stock jumps 90% after positive weight loss drug trial results
Publishing timestamp: 2024-02-27 11:13:40
Summary
Viking Therapeutics' shares soared after their weight loss drug showed promising results in a mid-stage trial. Analysts believe the weight loss drug industry could grow to a $100 billion market by the end of the decade. Larger pharmaceutical companies like Pfizer may consider acquiring Viking Therapeutics. The drug, VK2735, showed significant weight loss results in patients with obesity or who are overweight. The company plans to present full Phase 2 data and meet with the FDA to discuss further development steps.
Sentiment: POSITIVE
Keywords: business news, pharmaceuticals, business, biotech and pharmaceuticals, viking therapeutics inc, pfizer inc, biotechnology, health care industry, eli lilly and co, breaking news,